Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy
- Maria F. Acosta
- , Priya Muralidharan
- , Carissa L. Grijalva
- , Michael D. Abrahamson
- , Don Hayes
- , Jeffrey R. Fineman
- , Stephen M. Black
- , Heidi M. Mansour
Research output: Contribution to journal › Article › peer-review
13
Link opens in a new tab
Scopus
citations